Healthy donor faecal transplant for corticosteroid non-responsive severe alcoholic hepatitis

BMJ Case Reports

Volumn 2017, Issue , 2017, Pages

  Philips, Cyriac Abby ^a   Phadke, Nikhil ^b   Ganesan, Karthik ^c   Augustine, Philip ^d  

^a Ernakulam Medical Center   (India)

^b Molecular Cellular and Developmental Biology   (India)

^c Biomedical Software and Instrumentation   (United States)

^d Ernakulam Medical Centre   (India)

Author keywords

alcoholic liver disease; cirrhosis; portal hypertension

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; DISACCHARIDE; HEMOGLOBIN; PREDNISOLONE; RNA 16S; CORTICOSTEROID;

ABDOMINAL DISTENSION; ACTINOBACTERIA; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; APPETITE; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEROIDES; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHILD PUGH SCORE; CLINICAL ARTICLE; DISORIENTATION; FATTY LIVER; FECAL MICROBIOTA TRANSPLANTATION; FEVER; FIRMICUTES; FLAPPING TREMOR; FLATULENCE; FOOD INTAKE; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST; LOOSE FECES; MALE; MICROBIAL GENE; MODEL FOR END STAGE LIVER DISEASE SCORE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEOBACTERIA; SALVAGE THERAPY; DONOR; DRUG RESISTANCE; HOSPITAL ADMISSION; LIVER TRANSPLANTATION; PROCEDURES; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; DRUG RESISTANCE; FECAL MICROBIOTA TRANSPLANTATION; HEPATITIS, ALCOHOLIC; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 85034033801     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2017-222310     Document Type: Article

References (10)

1. Sohail U, Satapathy SK. Diagnosis and management of alcoholic hepatitis. Clin Liver Dis 2012;16:717-36.
2. Mathurin P, O'Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011;60:255-60.
3. Fung P, Pyrsopoulos N. emerging concepts in alcoholic hepatitis. World J Hepatol 2017;9:567-85.
4. Llopis M, Cassard AM, Wrzosek L, et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 2016;65:830-9.
5. Ferrere G, Wrzosek L, Cailleux F, et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol 2017;66:806-15.
6. Philips CA, Pande A, Shasthry SM, et al. Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study. Clin Gastroenterol Hepatol 2017;15:600-2.
7. Spahr L, Lambert J F, rubbia-Brandt L, et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 2008;48:221-9.
8. Bajaj JS, Kassam Z, Fagan A, et al. Fecal microbiota transplant from a rational stool donor improves Hepatic encephalopathy: a randomized clinical trial. Hepatology 2017.
9. Philips CA, Shasthry SM, Pande A, et al. Fecal microbiota transplantation (FMT) improves outcome and survival in steroid ineligible severe alcoholic hepatitis-A randomized control trial (NCT 02458079). Hepatology 2016;64:706A.
10. Li SS, Zhu A, Benes V, et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 2016;352:586-9.